iCAD INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-12-28: Reporting owner SALLAM MAHA; Form 4; Security Employee Options (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-10-20: Reporting owner SUSSMAN ELLIOT J MD MBA; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-10-20: Reporting owner RAPPAPORT STEVEN N; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-10-20: Reporting owner HOWARD DR LAWRENCE; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-12-28 | SALLAM MAHA Director | 4 | Employee Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −56,250 1,147,184 owned after | $0.80 exercise price | 2009-12-30 | |
| 2009-10-20 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,396 14,396 owned after | $2.03 exercise price | 2009-10-22 | |
| 2009-10-20 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,942 15,942 owned after | $2.03 exercise price | 2009-10-22 | |
| 2009-10-20 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $2.03 exercise price | 2009-10-22 | |
| 2009-10-20 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $2.03 exercise price | 2009-10-22 | |
| 2009-10-20 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,679 12,679 owned after | $2.03 exercise price | 2009-10-22 | |
| 2009-07-20 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,134 19,134 owned after | $1.22 exercise price | 2009-07-21 | |
| 2009-07-20 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,698 21,698 owned after | $1.22 exercise price | 2009-07-21 | |
| 2009-07-20 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $1.22 exercise price | 2009-07-21 | |
| 2009-07-20 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $1.22 exercise price | 2009-07-21 | |
| 2009-07-20 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,564 18,564 owned after | $1.22 exercise price | 2009-07-21 | |
| 2009-04-20 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $1.01 exercise price | 2009-04-22 | |
| 2009-04-20 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,454 20,454 owned after | $1.01 exercise price | 2009-04-22 | |
| 2009-04-20 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,934 23,934 owned after | $1.01 exercise price | 2009-04-22 | |
| 2009-04-20 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,674 25,674 owned after | $1.01 exercise price | 2009-04-22 | |
| 2009-04-20 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $1.01 exercise price | 2009-04-22 | |
| 2009-01-20 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $1.39 exercise price | 2009-01-22 | |
| 2009-01-20 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,566 18,566 owned after | $1.39 exercise price | 2009-01-22 | |
| 2009-01-20 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,865 20,865 owned after | $1.39 exercise price | 2009-01-22 | |
| 2009-01-20 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,990 14,990 owned after | $1.39 exercise price | 2009-01-22 | |
| 2009-01-20 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $1.39 exercise price | 2009-01-22 |